drugset / Trial / NCT01565330
A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
Non-randomizedParallel-groupSingle-blindDiagnostic
Summary
This study will test two different doses of florbetapir F 18 to determine which dose is best to image amyloid plaques in the brains of Alzheimer's Disease (AD) patients using a positron emission tomography (PET) scanner.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 111 mbq | Intravenous |
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 370 mbq | Intravenous |